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Introduction
Optic neuritis (ON) is a demyelinating inflammatory 
disease of the optic nerve that typically affects young 
adults especially females.[1] Many cases of optic neuritis are 
associated with multiple sclerosis or neuromyelitis optica 
or can occur in isolation.[2] The association between optic 
neuritis and multiple sclerosis is well established.[1] Bilateral 
optic neuritis has been reported in a Nigerian patient with 
neuromyelitis optica (Devic’s disease).[3] Occasionally, 
ON can result from infectious processes involving the 
paranasal sinuses[2] or occur in the course of a systemic 
viral infection.[4,5]
A diagnosis of optic neuritis is most often based on 
accepted clinical criteria which include loss of vision, 
dyschromatopsia, and peri-ocular pain.[6] Other diagnostic 
criteria for optic neuritis may also include reduced 
perception of light intensity, Uhthoff’s phenomenon (visual 
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deficit induced by exercise or increased body temperature),[7] 
and Pulfrich phenomenon (visual stereo-illusion observed 
when a swinging pendulum bob is viewed through a neutral 
density filter in front of one eye). The initial attack of optic 
neuritis is unilateral in 70% of adult patients and bilateral in 
30%; and mean age of onset is in the third decade of life[8] 
with an annual incidence that ranges from 1.6 to 5.0 new 
cases per 100,000 population.[8,9]
The cause and treatment of optic neuritis are unclear, but 
prognosis for visual recovery is generally good[1] even though 
return of visual function is almost never complete.[1,10] After 
resolution of optic neuritis, almost all patients show some 
signs of optic nerve damage and even when a patient’s acuity 
recovers to 20/20, abnormalities frequently remain in other 
measures such as contrast sensitivity, color vision, and visual 
field.[11-13] Visual loss may be subtle or profound and may 
occur over hours (rarely) to days (most commonly). The 
nadir is usually about 1 week after the onset.[14]
The magnitude of the risk of multiple sclerosis after optic 
neuritis is uncertain. Previous studies have reported very 
disparate results, with the risk being reported to be as low as 
19% 5 years after MS[15] and others up to 50% 15 years later.[16]
Optic neuritis can sometimes result from an infectious 
process involving the orbit, paranasal sinuses or systemic viral 
disease.[17-20] It is second only to glaucoma as the most common 
acquired optic nerve disorder in persons younger than age 
50.[1] Though the diagnosis of optic neuritis is usually made on 
clinical grounds, in atypical cases, magnetic resonance imaging 
(MRI) is used to further characterize and exclude other disease 
processes. Magnetic resonance imaging is well established as 
the single most important predictor of risk of developing optic 
neuritis (Optic Neuritis Treatment Trial).[1] The imaging of 
the brain in optic neuritis is said to be more important than 
that of the optic nerves as this is the most valuable predictor 
for the development of subsequent multiple sclerosis in the 
presence of white-matter abnormalities.[21]
In the Optic Neuritis Treatment Trial (ONTT), the 5-year 
risk of developing multiple sclerosis was 16% in patients with 
normal brain MRI findings, 37% with 1-2 lesions, and 51% 
with 3 or more lesions. At 10 years, the only statistically 
significant difference was between no lesions (22% risk) and 
one or more lesions (56% risk).[19] Prior to the Optic Neuritis 
Treatment Trial, there were no well-established guidelines 
for treating optic neuritis as some experts advocated 
treatment with oral prednisone while others recommended 
no treatment. Although corticosteroids had been used to 
treat this disease, various studies have not demonstrated 
their effectiveness.[18-20,22,23]
The objective of the study was to determine the level of 
improvement of vision after an attack of optic neuritis in 
Port Harcourt, Nigeria.
Materials and Methods
Medical records of all cases of optic neuritis seen at the Eye 
Clinic of the University of Port Harcourt Teaching Hospital 
over a 5-year period (January 2006 to December 2010) were 
retrieved and relevant data including age, sex, presenting 
symptom, presenting visual acuity (Snellen chart), and 
visual acuity at discharge 12 weeks later were extracted.
Our diagnosis of optic neuritis was based on accepted 
clinical criteria only and these included loss of vision, 
dyschromatopsia (Ishihara pseudoisochromatic plates), and 
peri-ocular pain in addition to a sluggish pupil or a relative 
afferent pupillary defect (RAPD). Contrast sensitivity was 
assessed with the Pelli-Robson chart. For retrobulbar neuritis 
a normal optic nerve head appearance was necessary for 
diagnosis while for papillits, the presence of disc swelling was 
needed for diagnosis. None of our patients had any systemic 
involvement suggestive of multiple sclerosis or neuromyelitis 
optica. All the patients received oral prednisolone (1 mg/kg 
body weight) for 2 weeks. Exclusion criteria included case 
files with incomplete records (two), those lost to follow-up 
(four) and other causes of optic neuropathy such as 
glaucoma or trauma. Diabetics were also excluded. Data 
were analyzed using Epi-info Version 6.02 and P values less 
than 0.05 were considered significant.
Results
A total of 27 cases of optic neuritis were seen over a 5-year 
period out of a total patient population of 24,363. (This gives 
the proportion of optic neuritis as 0.1%.) There were 11 males 
(40.7%) and 16 females (59.3%) giving a male to female ratio 
of 2:3. Over 60% of the subjects were aged between 20 and 
49 years old [Table 1]. The mean age of those with optic 
neuritis was 26.7 ± 12.1. There were 20 cases of retro-bulbar 
neuritis (74.1%) and seven cases of papillitis (25.9%).
Table 2 shows the age and gender distribution of those with 
retro-bulbar neuritis. A total of 20 cases of retro-bulbar 
neuritis were seen. There were 8 males (40%) and 12 (60%) 
females giving a male to female ratio of 2:3. The mean age 
of those with retro-bulbar neuritis was 25.8 ± 11.1.
Table 1: Age and gender distribution of patients with 
optic neuritis
Age group (years) Gender (%) Total (%)
Male Female
<10 1 (3.7) 1 (3.7)
10-19 4 (14.8) 3 (11.1) 7 (30)
20-29 6 (22.2) 5 (18.5) 11 (40.7)
30-39  3 (11.1) 3 (11.1)
40-49 1 (3.7) 2 (7.4) 3 (11.1)
50-59 2 (7.4) 2 (7.4)
Total 11 (40.7) 16 (59.3) 27 (100)
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Table 3 shows the age and gender distribution of those 
with papillitis. A total of seven cases of papillitis were seen. 
There were three males (42.9%) and four females (57.1%) 
giving a male to female ratio of 3:4. The mean age of those 
with papillitis was 29.1 ± 15.3. There was a statistically 
significant difference between the mean age of those 
with retro-bulbar neuritis and papilltis (Chi square-12.52; 
P value - 0.00)
Nineteen patients had unilateral involvement (70.4%), 
while 8 (29.6%) subjects had bilateral involvement; making 
the total, 35 eyes of 27 patients [Table 4]. Over 75% of the 
cases at presentation had VAs<6/24; only 5 eyes (14.3%) 
had VAs better than 6/24 [Table 4]. Over 85% of those with 
bilateral disease were less than 25 years old and there was 
a slight female preponderance (M:F=1:1.3).
Table 5 shows that by the 12th week, most visual acuities 
(77.1%) had improved to 6/12 or better. In 18 eyes (52.4%) 
visual acuity was 6/6-6/9. There were no patients whose 
visual acuities remained at CF-NPL.
Discussion
In most parts of the world acute demyelinating optic neuritis 
(ON) is the most common cause of unilateral painful visual 
loss in young adults.[24] In this study, about 60% of those 
with optic neuritis were aged between 20 and 49 years, 
similar to other studies where young adults were found to 
be mainly affected by the disease.[24] Those with papillitis 
were however slightly older than those with retro-bulbar 
neuritis and this was statistically significant (Chi square 
12.52; P value 0.00). Over 70% of our patients had unilateral 
ocular involvement similar to Shams et al.[24] In our study, 
even though females were found to be more affected than 
males by the disease, the figure is still slightly lower than 
reports by other researchers.[24-28] The reason for this may 
not be unconnected with the fact that, in our environment, 
females are less likely to present themselves for treatment 
than males because of cultural barriers and widespread 
illiteracy. This therefore gives a false impression that females 
are not that much affected compared to other studies. In 
our study, retro-bulbar neuritis was responsible for about 
75% of all cases of optic neuritis similar to the result of the 
Optic Neuritis Treatment Trial Study.
In regions of the world where multiple sclerosis (MS) 
is common, most cases of ON are related to multiple 
sclerosis.[24] In our study, however, all the cases of optic 
neuritis occurred in isolation. This is not surprising as the 
incidence of multiple sclerosis associated optic neuritis 
(MSAON) is said to be very rare in blacks[29] and highest 
in Caucasians.[30]
At 12 weeks postpresentation, almost 80% of visual acuities 
had improved to 6/12 or better. This agrees with the widely 
documented evidence that visual acuity improves after an 
attack of optic neuritis.[6,31]
Table 2: Age and gender distribution of patients with 
retro-bulbar neuritis
Age group (years) Gender (%) Total (%)
Male Female
<10  1 (5) 1 (5)
10-19 3 (15) 3 (15) 6 (30)
20-29 4 (20) 3 (15) 7 (35)
30-39  3 (15) 3 (15)
40-49 1 (5) 1 (5) 2 (10)
50-59 1 (5) 1 (5)
Total 8 (40) 12 (60) 20 (100)
Table 3: Age and gender distribution of patients with 
papillitis
Age group (years) Gender (%) Total (%)
Male Female
10-19 1 (14.3)  1 (14.3)
20-29 2 (28.6) 2 (28.5) 4 (57.1)
30-39  1 (14.3) 1 (14.3)
40-49  1 (14.3) 1 (14.3)
Total 3 (42.9) 4 (57.1) 7 (100)
Table 4: Presenting visual acuity (VA) of patients with 
optic neuritis
Visual acuity Right eye (%) Left eye (%) Total (%)
6/18 2 (5.7) 3 (8.6) 5 (14.3)
6/24 1 (2.9) 2 (5.7) 3 (8.6)
6/36 3 (8.6) 3 (8.5) 6 (17.1)
6/60 4 (11.4) 5 (14.3) 9 (25.7)
CF 1 (2.9) 1 (2.9) 2 (5.7)
HM 3 (8.5) 1 (2.9) 4 (11.4)
NPL 5 (14.3) 1 (2.9) 6 (17.2)
Total 19 (54.3) 16 (45.7) 35 (100)
CF = Counting fingers, HM = Hand movement, NPL = No perception of 
light
Table 5: Visual acuity 12 weeks following optic 
neuritis
Visual acuity Right eye (%) Left eye (%) Total (%)
6/6 6 (17.1) 5 (14.3) 11 (31.4)
6/9 4 (11.4) 3 (8.6) 7 (20)
6/12 5 (14.3) 4 (11.4) 9 (25.7)
6/18 1 (2.9) 1 (2.9) 2 (5.7)
6/24 - - -
6/36 1 (2.9) 2 (5.7) 3 (8.6)
6/60 2 (5.7) 1 (2.9) 3 (8.6)
CF - - -
HM - - -
NPL - - -
Total 19 (54.3) 16 (45.7) 35 (100)
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About 50% of our patients however had some degree of 
reduction in quality of vision as assessed by color vision and 
contrast sensitivity. Since our patients were not followed 
up for a long time and none had magnetic resonance 
imaging (MRI), it is difficult to know if some were at risk 
of developing MS or if some could have gone on to develop 
multiple sclerosis. This relationship between optic neuritis 
and MS needs further elucidation in a homogenous black 
population such as ours.
Conclusion
This study has confirmed widely documented evidence 
that there is improvement in visual acuity after an attack 
of optic neuritis. It also lends credence to the known fact 
that optic neuritis is rare in blacks.[26] Even though the risk 
of developing MS following optic neuritis is said to be low in 
blacks, these patients should still be monitored for sometime 
especially as some may go on to develop other complications 
of demyelination. To fully substantiate some of these findings 
however, a prospective study on optic neuritis using the ONTT 
guideline and a larger sample size is proposed for future studies.
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